Y. Gillespie

Cross-species genomics matches driver mutations and cell compartments to model ependymoma

Amar Gajjar, Stanley B. Pounds, Richard G. Grundy, 2010, Nature.

Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma

Paul A. Northcott, J. S. Rao, Boleslaw Lach, 2009, Nature Genetics.

Design and Rationale for First-In-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors.

J. Johnston, J. Markert, J. Fiveash, 2020, Human gene therapy.

Use of chlorotoxin for targeting of primary brain tumors.

M. Khazaeli, L. Soroceanu, H. Sontheimer, 1998, Cancer research.

Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance

S. Cooper, D. Harrison, J. Pollock, 2018, Neuro-oncology.

A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas.

B. Thompson, J. Markert, G. Roldan, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.

Richard Grundy, David W Ellison, C. Croce, 2009, Cancer research.

Treated Cerebellar Neural Precursors − in Sonic Hedgehog Driven Medulloblastomas and Induced by N-myc − Hedgehog The miR-17 / 92 Polycistron Is Up-regulated in Sonic

C. Croce, P. Northcott, J. Rutka, 2009 .

EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY

Tina N. Davis, Forrest M Kievit, Atique U. Ahmed, 2013 .

Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.

J. Markert, Y. Gillespie, K. Riley, 2016, Human gene therapy. Clinical development.